809 — Global Bio-chem Technology Co Balance Sheet
0.000.00%
- HK$1.31bn
- HK$6.49bn
- HK$2.00bn
- 13
- 86
- 19
- 30
Annual balance sheet for Global Bio-chem Technology Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 153 | 21.8 | 41.8 | 316 | 85.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 787 | 356 | 279 | 396 | 1,722 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,242 | 592 | 688 | 970 | 2,100 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,354 | 5,887 | 5,158 | 4,220 | 2,409 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 7,602 | 6,483 | 5,850 | 5,209 | 4,542 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12,360 | 12,036 | 13,506 | 8,396 | 6,486 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 13,463 | 13,000 | 13,389 | 9,246 | 6,497 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | -5,861 | -6,518 | -7,539 | -4,037 | -1,954 |
| Total Liabilities & Shareholders' Equity | 7,602 | 6,483 | 5,850 | 5,209 | 4,542 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |